Pharm: Insomnia and Migraine Flashcards
GABA
- location
- function
- basal forebrain
2. negative regulator of ascending pathways and of neuronal activity in the cortex
orexin
- location
- function
- stimulates
- regulated by
- lateral hypothalamus
- rapid transition btwn see and wake state
- monoaminergic nuclei, dopaminergic centers, neuropeptide Y
- suprachiasmatic nucleus and limbic system (emotional arousal)
ascending pathways of arousal
- cholinergic: activate thalamus
2. activate cerebral cortex: histamine, dopamine, serotonin, NE, orexin, MCH, GABA (inhibition)
NT at each location for ascending pathway of arousal
- upper pons, pedunculopontine, laterodorsal tegmental nuclei
- tuberomammillary nucleus
- A10 cell group
- dorsal and median raphe nuclei
- locus coerulus
- lateral hypothalamus
- basal forebrain
- cholinergic
- histamine
- dopamine
- serotonin
- NE
- orexin or MCH
- GABA
monoamergic nuclei
promote wakefulness
dopaminergic centers
reward systems
neuropeptide Y
increase food intake
benzodiazepines
-zepam/-zolam
increase frequency of GABA channel opening: binds alpha subunit
acts on BZ-1, 2 and 3
CYP3A4
Tx: insomnia
safer than barbiturate
AE: PHYSICAL DEPENDENCE, rebound, sedation/ cognitive impairment
CI: PREGNANCY
caution: HEPATIC, COPD, DEPRESSION, DRIVING, CNS drug interactions, GLAUCOMA
antidepressants
TCA works thru: H1 antagonism CYP Tx: insomnia (off label) DI: alcohol, CNS depressants BBW: SUICIDAL IDEATION
benzodiazepine receptor agonists
oral: formulated with immediate and extended release ZZZ's acts on BZ-1 CYP can use in pregnant Tx: insomnia AE: PHYSICAL DEPENDENCE caution: HEPATIC, COPD, DEPRESSION, DRIVING, CNS drug interactions
1st generation antihistamines
OTC H1 antagonist Tx: insomnia (off label) AE: anticholinergic: xerostomia, blurred vision, urinary retention, increased intraocular pressure RAPID TOLERANCE to sedation caution: narrow angle GLAUCOMA
ramelteon
melatonin receptor agonist suprachiasmatic nucleus inhibition CYP Tx: insomnia (off label) AE: FEW; headache, somnolence, nausea, insomnia, URTI
suvorexant
oral dual orexin receptor antagonist w/out food: delays action CYP3A4 reduce dose: OBESE FEMALES Tx: insomnia AE: SOMNOLENCE (driving), SUICIDAL IDEATION, narcoleptic (SLEEP PARALYSIS, hallucinations) CI: alcohol, CNS depressants, narcolepsy
estazolam
benzodiazepine
short T1/2
inactive metabolites
flurazepam
benzodiazepine
accumulation of metabolites
quazepam
benzodiazepine
accumulation of metabolites
CYPB6 > CYP3A4
temazepam
benzodiazepine
NO CYP
triazolam
benzodiazepine
doxepin
only FDA approved antidepressant for insomnia
also: NE, 5-HT reuptake blocker, anticholinergic
mirtazapine
antidepressant
trazodone
antidepressant
zolpidem
oral nasal, sublingual: fast onset benzodiazepine receptor agonist short-acting: approved for middle of the nigh awakening (only indication for sublingual formulation) WOMEN: reduce dose
zaleplon
benzodiazepine receptor agonist
Aldehyde DH
ethnic variability: ASIAN
eszopiclone
benzodiazepine receptor agonist
diphenhydramine
1st gen. antihistamine
doxylamine
1st gen. antihistamine
concerns with drugs to treat insomnia
- somnolence (driving)
- unconscious night activity
- suicide ideation
- narcolepsy-associated events (sleep paralysis, hallucination, mild cataplexy)
GABA-A receptor
Cl- channel
barbiturates
increase duration of GABA channel opening
Tx: insomnia
AE: profound CNS depression that is lethal at high doses
Why are benzodiazepines safer than barbiturates?
benzodiazepines have a CEILING EFFECT at high doses
only lethal when consumed with alcohol
Benzodiazepine signs of withdrawal
- anxiety, irritable, restless
- obstructing sleep apnea
- severe ventilatory impairment
- caution with tapering
- BZ-1
- BZ-2
- BZ-3
- sedation, amnesia
- anxiolysis
- myorelaxation, anticonvulsant
midazolam
benzodiazepine
short T1/2
diazepam
benzodiazepine
long T1/2